Business Description
Sartorius AG
ISIN : DE0007165631
Share Class Description:
XBUL:SRT3: Vorz-Inhaber-Akt ohne StimmrechtCompare
Compare
Traded in other countries / regions
SRT.Germany0NIR.UKSOAGY.USASRT3.Bulgaria1SRT3.ItalySRT3.AustriaSRT3.Mexico IPO Date
2021-12-09Description
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 1.7 | |||||
| Debt-to-EBITDA | 5.69 | |||||
| Interest Coverage | 2.09 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.93 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.7 | |||||
| 3-Year EBITDA Growth Rate | 40.7 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | 29.4 | |||||
| 3-Year Book Growth Rate | 26.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 39.85 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.91 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.99 | |||||
| 9-Day RSI | 98.97 | |||||
| 14-Day RSI | 94.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.63 | |||||
| Days Inventory | 201.35 | |||||
| Days Sales Outstanding | 39.06 | |||||
| Days Payable | 74.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.58 | |||||
| Dividend Payout Ratio | 0.25 | |||||
| 3-Year Dividend Growth Rate | 59.9 | |||||
| Forward Dividend Yield % | 0.58 | |||||
| 5-Year Yield-on-Cost % | 1.84 | |||||
| Shareholder Yield % | -12.99 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.22 | |||||
| Operating Margin % | 13.37 | |||||
| Net Margin % | 5.99 | |||||
| FCF Margin % | 14.44 | |||||
| ROE % | 8.17 | |||||
| ROA % | 1.99 | |||||
| ROIC % | 3.42 | |||||
| 3-Year ROIIC % | 0.99 | |||||
| ROC (Joel Greenblatt) % | 14.87 | |||||
| ROCE % | 4.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 58.48 | |||||
| Forward PE Ratio | 23.87 | |||||
| PE Ratio without NRI | 58.48 | |||||
| Shiller PE Ratio | 46.43 | |||||
| Price-to-Owner-Earnings | 27.69 | |||||
| PEG Ratio | 1.17 | |||||
| PS Ratio | 3.63 | |||||
| PB Ratio | 4.51 | |||||
| Price-to-Free-Cash-Flow | 25.22 | |||||
| Price-to-Operating-Cash-Flow | 13.07 | |||||
| EV-to-EBIT | 46.03 | |||||
| EV-to-Forward-EBIT | 28.36 | |||||
| EV-to-EBITDA | 23.03 | |||||
| EV-to-Forward-EBITDA | 18.06 | |||||
| EV-to-Revenue | 5.52 | |||||
| EV-to-Forward-Revenue | 5.03 | |||||
| EV-to-FCF | 36.07 | |||||
| Price-to-GF-Value | 0.84 | |||||
| Price-to-Projected-FCF | 1.94 | |||||
| Price-to-DCF (Earnings Based) | 1.1 | |||||
| Price-to-DCF (FCF Based) | 0.47 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.44 | |||||
| Earnings Yield (Greenblatt) % | 2.17 | |||||
| FCF Yield % | 3.32 | |||||
| Forward Rate of Return (Yacktman) % | 19.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sartorius AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil лв) | 6,710.389 | ||
| EPS (TTM) (лв) | 6.014 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 94.03 | ||
| 14-Day ATR (лв) | 0.059487 | ||
| 20-Day SMA (лв) | 251.3 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (лв) | 207 - 251.3 | ||
| Shares Outstanding (Mil) | 69.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sartorius AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sartorius AG Stock Events
| Event | Date | Price (лв) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sartorius AG Frequently Asked Questions
What is Sartorius AG(XBUL:SRT3)'s stock price today?
The current price of XBUL:SRT3 is лв251.30. The 52 week high of XBUL:SRT3 is лв251.30 and 52 week low is лв207.00.
When is next earnings date of Sartorius AG(XBUL:SRT3)?
The next earnings date of Sartorius AG(XBUL:SRT3) is 2025-01-18 Est..
Does Sartorius AG(XBUL:SRT3) pay dividends? If so, how much?
The Dividend Yield %  of Sartorius AG(XBUL:SRT3) is 0.58% (As of Today), Highest Dividend Payout Ratio of Sartorius AG(XBUL:SRT3) was 0.61. The lowest was 0.08. And the median was 0.21. The  Forward Dividend Yield % of Sartorius AG(XBUL:SRT3) is 0.58%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers